DSC_5438 website

Preliminary programme of the 11th Conference on HIV Pathogenesis, Epidemiology, Prevention and Treatment

08:00 Registration
Opening remarks
09:00 Opening and welcome Peter Reiss (SHM; AMC-UvA; AIGHD, Amsterdam)
Session 1: Looking beyond 90-90-90
Chairs:   Bruno Ledergerber (University Hospital Zurich) & Annelies Verbon (Erasmus MC)
09:10-09:30 The HIV epidemic in the Netherlands: an update  Peter  Reiss (Stichting HIV Monitoring; AMC-UvA; AIGHD, Amsterdam)
09:30-09:40 Many introductions but little transmission of HIV 1 non B subtypes in the Netherlands Daniela Bezemer (Stichting HIV Monitoring, Amsterdam)
09:40-09:50 Geospatial analysis and mapping of new HIV diagnoses, late presentations and GP testing practices in Amsterdam Lene Böhnke (AHTI, Amsterdam)
09:50-10:00 A qualitative study of perceived barriers and facilitators to the implementation of Social Network Testing for HIV among MSM with a non-Western migration background Chantal den Daas (RIVM, Bilthoven)
10:00-10:30 Plenary: HIV-related issues in people with a migrant background  Julia Del Amo (Instituto de Salud Carlos III, Madrid)
10:30-10:40 General discussion
10:40-11:10 Refreshment break & poster viewing
Session 2: Restricting resistance and reaching the reservoir
Chairs: Ben Berkhout (AMC) & Kees Brinkman (OLVG)
11:10-11:40 Plenary:  Long acting formulations for HIV treatment and prevention Daniel Kuritzkes (Brigham & Women’s Hospital, Boston)
11:40-11:50 Dynamics of HIV 1 resistance in patients treated with dolutegravir maintenance monotherapy Jeroen van Kampen (Erasmus MC, Rotterdam)
11:50-12:00 Previous antiretroviral drug use compromises standard first line therapy in Africa and is mediated through drug resistance Seth Inzaule (AIGHD, Amsterdam)
12:00-12:10 Protective efficacy of broadly neutralizing antibody PGDM1400 against HIV 1 in humanized mice Marit van Gils (AMC-UvA, Amsterdam)
12:10-12:20 HIV-1 infection in macrophages reduces expression of pro inflammatory genes Zita Kruize (AMC-UvA, Amsterdam)
12:20-12:30 The CCR5 agonist Maraviroc reverses HIV latency, results from ex vivo studies and a randomized placebo controlled clinical trial Jori Symons (UMC Utrecht, Utrecht)
12:30-12:45 General discussion
12:45-14:05 Lunch
12:55-14:05 Oral poster discussion session: reaching and serving key populations

[programme below]

12:55-14:05 Poster viewing
Session 3: Towards improved understanding and prevention of transmission
Chairs:   Godelieve de Bree (AMC) & John de Wit (Utrecht University)
14:05-14:35 Plenary: How HIV infiltrates our immune system and lessons on how to strike back Theo Geijtenbeek (AMC-UvA, Amsterdam)
14:35-14:45 HIV-1 enhances sexual transmission of Hepatitis C virus by human mucosal Langerhans cells Bernadien Nijmeijer (AMC-UvA, Amsterdam)
14:45-14:55 HIV and sexually transmitted infections in daily and event-driven PrEP users: interim results from the Amsterdam PrEP demonstration project Elske Hoornenborg (GGD Amsterdam, Amsterdam)
14:55-15:05 Pre exposure prophylaxis (PrEP) among men who have sex with men (MSM) in the Amsterdam Cohort Studies (ACS): Eligibility, intention and actual use Ward van Bilsen (GGD Amsterdam, Amsterdam)
15:05-15:15 Abortive HIV-1 RNA transcripts enhance immunity against HIV-1 Melissa Stunnenberg (AMC-UvA, Amsterdam)
15:15-15:25 General discussion
15:25-15:55  Refreshment break & poster viewing
Session 4: Achieving epidemic control
Chairs: Roel Coutinho (UMC Utrecht, Utrecht) & Catherine Hankins (AIGHD)
15:55-16:25 Plenary:   Ending the HIV epidemic in New York: lessons from New Amsterdam Demetre Daskalakis (New York City Dept. Health & Mental Hygiene, New York)
16:25-16:35 Estimating HIV incidence and the undiagnosed HIV population in the European Union/European Economic Area Ard van Sighem (Stichting HIV Monitoring, Amsterdam)
16:35-16:45 Cost-effectiveness of increased HIV testing among men who have sex with men in the Netherlands Maarten Reitsema (RIVM, Bilthoven)
16:45-16:55 Vaginal dysbiosis-associated bacteria Prevotella strongly increases HIV-1 susceptibility of Langerhans cells and CD4  T cells in human vaginal mucosa Nienke van Teijlingen (AMC-UvA, Amsterdam
16:55-17:05 Autophagy restricts mucosal HIV-1 transmission and drives protective antiviral T-cell immunity Carla Ribeiro (AMC-UvA, Amsterdam)
17:05-17:20 General discussion
17:20-17:30 Closing & presentation of Joep Lange and Jacqueline van Tongeren young investigator award Timothy Brown &  Peter Reiss (SHM; AIGHD; AMC-UvA)
17:30 Drinks


Oral poster discussion: Reaching and serving key populations
Chairs: Alexander Pastoors (Hiv Vereniging) & Demetre Daskalakis (New York City Dept. Health & Mental Hygiene, New York)
13:00 Opening
13:05 Differences in access to HIV testing, treatment and healthcare among non-migrants and migrants living with HIV in the Netherlands: a cross-sectional study Janneke Bil (GGD Amsterdam, Amsterdam)
13:10 Community-based rapid HIV testing; addressing the needs of the MSM community in the Netherlands Anna Zakowicz (AIDS Healthcare Foundation Europe, Amsterdam)
13:15 Partner notification among men who have sex with men newly diagnosed with HIV at the Public Health Service of Amsterdam Oletta Eijpe (GGD Amsterdam, Amsterdam)
13:20 Attituted towards PrEP among the general public: effects of framing different target populations for PrEP use Mart van Dijk (Maastricht University, Maastricht)
13:25 Pre-exposure prophylaxis (PrEP) among MSM in the Netherlands: motives for starting, choosing for, switching to, or stopping with daily or event-driven: lessons for future PrEP implementation Hanne Zimmermann (GGD Amsterdam, Amsterdam)
13:30-14:05 Moderated discussion